• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

审视冷链在疫苗配送中的重要性。

Reviewing the importance of the cold chain in the distribution of vaccines.

作者信息

Purssell Edward

机构信息

Senior Lecturer, King's College, London, England.

出版信息

Br J Community Nurs. 2015 Oct;20(10):481-6. doi: 10.12968/bjcn.2015.20.10.481.

DOI:10.12968/bjcn.2015.20.10.481
PMID:26418400
Abstract

Vaccination is an effective public health measure to prevent and control a number of infectious diseases. However, since vaccines are biological products and are sensitive to both heat and cold, they need to be maintained within a narrow range of temperatures, often referred to as the 'cold-chain'. This range, which is between +2°C and +8°C with a target +5°C, does not allow for refreezing or storage at room temperature. This paper discusses the importance of the cold chain, what should be done both to maintain it, and the actions to be taken, should a break be noted. It is important to note the product information supplied with vaccines, which is taken from the summary of product characteristics that forms part of the licensing requirements for each vaccine, and which will state how it should be stored. Using a vaccine that has not been stored according to these instructions constitutes off-label use, for which the individual practitioner must take responsibility. It also emphasises the fragile nature of many public health interventions, maintenance of which require constant vigilance and close cooperation between many groups and individuals.

摘要

疫苗接种是预防和控制多种传染病的一项有效公共卫生措施。然而,由于疫苗是生物制品,对热和冷都很敏感,它们需要在一个较窄的温度范围内保存,通常称为“冷链”。这个范围是2°C至8°C,目标温度为5°C,不允许再次冷冻或在室温下储存。本文讨论了冷链的重要性、维持冷链应采取的措施以及发现冷链中断时应采取的行动。必须注意疫苗附带的产品信息,这些信息取自产品特性摘要,而产品特性摘要是每种疫苗许可要求的一部分,其中会说明疫苗应如何储存。使用未按照这些说明储存的疫苗属于超说明书用药,个体从业者必须对此负责。本文还强调了许多公共卫生干预措施的脆弱性,维持这些措施需要许多团体和个人不断保持警惕并密切合作。

相似文献

1
Reviewing the importance of the cold chain in the distribution of vaccines.审视冷链在疫苗配送中的重要性。
Br J Community Nurs. 2015 Oct;20(10):481-6. doi: 10.12968/bjcn.2015.20.10.481.
2
Is freezing in the vaccine cold chain an ongoing issue? A literature review.疫苗冷链中的冻结是一个持续存在的问题吗?一项文献综述。
Vaccine. 2017 Apr 19;35(17):2127-2133. doi: 10.1016/j.vaccine.2016.09.070.
3
Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®).热稳定、减毒活轮状病毒疫苗(ROTASIIL®)的稳定性。
Vaccine. 2017 May 19;35(22):2962-2969. doi: 10.1016/j.vaccine.2017.04.025. Epub 2017 Apr 20.
4
Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.热稳定疫苗能否帮助应对冷链挑战?来自六个低收入和中等收入国家的利益相关者访谈结果。
Vaccine. 2016 Feb 10;34(7):899-904. doi: 10.1016/j.vaccine.2016.01.001. Epub 2016 Jan 8.
5
Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions.印度尼西亚冷链中乙肝疫苗的冻结:证据与解决方案
Bull World Health Organ. 2004 Feb;82(2):99-105. Epub 2004 Mar 16.
6
Cold chain in a hot climate.炎热气候下的冷链
Aust N Z J Public Health. 1996 Dec;20(6):657-60. doi: 10.1111/j.1467-842x.1996.tb01084.x.
7
[Evaluation of the cold chain during the national antipoliomyelitis vaccination days. Mexico, 1987-1988].[1987 - 1988年墨西哥全国脊髓灰质炎疫苗接种日期间冷链评估]
Salud Publica Mex. 1990 Jan-Feb;32(1):43-51.
8
Vaccine transport and storage: environmental challenges.疫苗运输与储存:环境挑战
Dev Biol Stand. 1996;87:9-17.
9
Seizing market shaping opportunities for vaccine cold chain equipment.抓住疫苗冷链设备的市场塑造机遇。
Vaccine. 2017 Apr 19;35(17):2260-2264. doi: 10.1016/j.vaccine.2016.12.073.
10
Use of adenovirus as a model system to illustrate a simple method using standard equipment and inexpensive excipients to remove live virus dependence on the cold-chain.使用腺病毒作为模型系统,以说明一种使用标准设备和廉价辅料去除活病毒对冷链依赖的简单方法。
Vaccine. 2014 May 19;32(24):2931-8. doi: 10.1016/j.vaccine.2014.02.033. Epub 2014 Mar 21.

引用本文的文献

1
SARS-CoV-2 IgG antibody status in unvaccinated and 2-dose vaccinated Indonesians by AstraZeneca.未接种疫苗以及接种两剂阿斯利康疫苗的印度尼西亚人新冠病毒2型免疫球蛋白G抗体状态
J Public Health Afr. 2023 Dec 1;14(12):2697. doi: 10.4081/jphia.2023.2697. eCollection 2023 Dec 27.
2
Assessment of vaccination service delivery and quality: a cross-sectional survey of over 1300 health facilities from 29 districts in Sindh, Pakistan conducted between 2017-18.评估疫苗接种服务提供和质量:2017-18 年在巴基斯坦信德省 29 个地区的 1300 多家卫生机构进行的横断面调查。
BMC Health Serv Res. 2022 Jun 1;22(1):727. doi: 10.1186/s12913-022-08098-9.
3
Lessons learned from COVID-19 vaccination in Indonesia: experiences, challenges, and opportunities.
从印度尼西亚的 COVID-19 疫苗接种中吸取的经验教训:经验、挑战和机遇。
Hum Vaccin Immunother. 2021 Nov 2;17(11):3898-3906. doi: 10.1080/21645515.2021.1975450. Epub 2021 Oct 6.
4
Dry Formulation of Virus-Like Particles in Electrospun Nanofibers.电纺纳米纤维中病毒样颗粒的干制剂
Vaccines (Basel). 2021 Mar 3;9(3):213. doi: 10.3390/vaccines9030213.
5
How the use of vaccines outside the cold chain or in controlled temperature chain contributes to improving immunization coverage in low- and middle-income countries (LMICs): A scoping review of the literature.冷链之外或在温控链中使用疫苗如何有助于提高低收入和中等收入国家(LMICs)的免疫接种覆盖率:文献综述
J Glob Health. 2021 Jan 31;11:04004. doi: 10.7189/jogh.11.04004.